Ki-67 protein concentrations in urothelial bladder carcinomas are related to Ki-67-specific RNA concentrations in urine

Clinical Chemistry

Volumn 50, Issue 8, 2004, Pages 1461-1463

  Menke, Tim B ^a   Boettcher, Katrin ^a   Krüger, Stefan ^a   Kausch, Ingo ^a   Boehle, Andreas ^b   Sczakiel, Georg ^a   Warnecke, Jens M ^a,c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b HELIOS AGNES KARLL HOSPITAL   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY KI 67; RNA;

ARTICLE; BLADDER CARCINOMA; CALCULATION; CONTROLLED STUDY; CYSTECTOMY; DILUTION; HUMAN; HUMAN TISSUE; INCUBATION TIME; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN URINE LEVEL; TRANSURETHRAL RESECTION; UROGENITAL TRACT TUMOR; WORLD HEALTH ORGANIZATION;

CARCINOMA, TRANSITIONAL CELL; HUMANS; KI-67 ANTIGEN; POLYMERASE CHAIN REACTION; REFERENCE VALUES; RNA; ROC CURVE; URINARY BLADDER NEOPLASMS;

EID: 3242784126     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.030049     Document Type: Article

References (13)

1. Scholzen T, Endl E, Wohlenberg C, van der Sar S, Cowell IG, Gerdes J, et al. The Ki-67 protein interacts with members of the heterochromatin protein 1 (HP1) family: a potential role in the regulation of higher-order chromatin structure. J Pathol 2002;196:135-44.
2. Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, Smeets AW, Pauwels RP. MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: clinical significance and comparison with other prognostic factors. Cancer 2000;88:2598-605.
3. Suwa Y, Takano Y, Iki M, Asakura T, Noguchi S, Masuda M. Prognostic significance of Ki-67 expression in transitional cell bladder carcinoma after radical cystectomy. Pathol Res Pract 1997;193:551-6.
4. Santos L, Amaro T, Costa C, Pereira S, Bento MJ, Lopes P, et al. Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification. Int J Cancer 2003;105:267-72.
5. Menke TB, Warnecke JM. Improved conditions for isolation and quantification of RNA in urine specimen. Ann N Y Acad Sci; in press.
6. Mostofi FK, Davis CJ Jr, Sesterhenn IA. Histological typing of urinary bladder tumors. World Health Organization - international histological classification of tumors. Berlin: Springer, 1999:10-1.
7. Sobin LH, Wittekind C, eds. TNM classification of malignant tumors, 6th ed. Berlin: Springer, 2002:187-9.
8. Krüger S, Müller H. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki-67 antigen expression with grading and staging in urinary bladder carcinomas. Br J Urol 1995;75:480-4.
9. Bialkowska-Hobrzanska H, Bowles L, Bukala B, Joseph MG, Fletcher R, Razvi H. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma. Mol Diagn 2000;4:267-77.
10. Miyake H, Eto H, Arakawa S, Kamidono S, Hara I. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer. J Urol 2002;167:1282-7.
11. Okegawa T, Kinjo M, Horie S, Nutahara K, Higashihara E. Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor. Urology 2003;2:182-6.
12. Chiu AW, Huang YL, Huan SK, Wang YC, Ju JP, Chen MF, et al. Potential molecular marker for detecting transitional cell carcinoma. Urology 2002;60:181-5.
13. Hotakainen K, Haglund C, Paju A, Nordling S, Alfthan H, Rintala E, et al. Chorionic gonadotropin β-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue. Eur Urol 2002;41:677-85.